First Manhattan CO. LLC. Sells 521 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

First Manhattan CO. LLC. reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 31.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,137 shares of the medical equipment provider’s stock after selling 521 shares during the quarter. First Manhattan CO. LLC.’s holdings in Intuitive Surgical were worth $593,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in ISRG. Czech National Bank boosted its holdings in shares of Intuitive Surgical by 6.9% in the 4th quarter. Czech National Bank now owns 77,227 shares of the medical equipment provider’s stock valued at $40,309,000 after buying an additional 4,970 shares during the last quarter. Fiduciary Alliance LLC boosted its holdings in shares of Intuitive Surgical by 33.7% in the 4th quarter. Fiduciary Alliance LLC now owns 12,497 shares of the medical equipment provider’s stock valued at $6,523,000 after buying an additional 3,151 shares during the last quarter. Brookstone Capital Management boosted its holdings in shares of Intuitive Surgical by 25.4% in the 4th quarter. Brookstone Capital Management now owns 18,102 shares of the medical equipment provider’s stock valued at $9,448,000 after buying an additional 3,663 shares during the last quarter. Capital Investment Advisors LLC boosted its holdings in shares of Intuitive Surgical by 15.6% in the 4th quarter. Capital Investment Advisors LLC now owns 899 shares of the medical equipment provider’s stock valued at $469,000 after buying an additional 121 shares during the last quarter. Finally, Kieckhefer Group LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $5,632,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $536.55 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $379.67 and a fifty-two week high of $616.00. The company has a market capitalization of $192.31 billion, a P/E ratio of 83.71, a P/E/G ratio of 5.85 and a beta of 1.70. The stock has a fifty day moving average of $500.93 and a 200-day moving average of $535.03.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter last year, the business earned $1.50 earnings per share. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the firm’s stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. The trade was a 53.61% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,044 shares of company stock worth $17,070,433. Company insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. UBS Group raised their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Wells Fargo & Company raised their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Royal Bank of Canada cut their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.